Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007784. doi: 10.1002/14651858.CD007784. Review. Update in: Cochrane Database Syst Rev. 2014;5:CD007784.

PMID:
19370693
2.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 May 31;(5):CD007784. doi: 10.1002/14651858.CD007784.pub2. Review.

PMID:
24880031
3.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD005019. doi: 10.1002/14651858.CD005019.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD005019.

PMID:
19370615
4.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004289. doi: 10.1002/14651858.CD004289.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004289.

PMID:
19370598
5.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004289. doi: 10.1002/14651858.CD004289.pub4. Review.

PMID:
19588351
6.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD005019. doi: 10.1002/14651858.CD005019.pub4. Review.

PMID:
24470059
7.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD004289. doi: 10.1002/14651858.CD004289.pub5. Review.

PMID:
24022428
8.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Navaneethan SD, Shrivastava R.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004289. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD004289.

PMID:
15495097
9.

Antioxidants for chronic kidney disease.

Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008176. doi: 10.1002/14651858.CD008176.pub2. Review.

PMID:
23076940
10.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
11.

Lipid-lowering agents for nephrotic syndrome.

Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.

Cochrane Database Syst Rev. 2013 Dec 10;(12):CD005425. doi: 10.1002/14651858.CD005425.pub2. Review.

PMID:
24327265
12.

Statins for the primary prevention of cardiovascular disease.

Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004816. doi: 10.1002/14651858.CD004816.pub5. Review.

PMID:
23440795
13.

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.

Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC.

BMJ. 2008 Mar 22;336(7645):645-51. doi: 10.1136/bmj.39472.580984.AE. Epub 2008 Feb 25. Review. Erratum in: BMJ. 2009;339:b2951.

14.

Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.

Izquierdo-Palomares JM, Fernandez-Tabera JM, Plana MN, Añino Alba A, Gómez Álvarez P, Fernandez-Esteban I, Saiz LC, Martin-Carrillo P, Pinar López Ó.

Cochrane Database Syst Rev. 2016 Nov 26;11:CD009462. Review.

PMID:
27888640
15.

Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.

Strippoli GF, Navaneethan SD, Craig JC.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003967. Review.

PMID:
17054191
16.

Aldosterone antagonists for preventing the progression of chronic kidney disease.

Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007004. doi: 10.1002/14651858.CD007004.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD007004.

PMID:
19588415
17.

Vitamin D compounds for people with chronic kidney disease not requiring dialysis.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD008175. doi: 10.1002/14651858.CD008175. Review.

PMID:
19821446
18.

Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.

Strippoli GF, Manno C, Schena FP, Craig JC.

Cochrane Database Syst Rev. 2003;(1):CD003967. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003967.

PMID:
12535495
19.

Altered dietary salt intake for people with chronic kidney disease.

McMahon EJ, Campbell KL, Bauer JD, Mudge DW.

Cochrane Database Syst Rev. 2015 Feb 18;(2):CD010070. doi: 10.1002/14651858.CD010070.pub2. Review.

PMID:
25691262
20.

Exercise training for adults with chronic kidney disease.

Heiwe S, Jacobson SH.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD003236. doi: 10.1002/14651858.CD003236.pub2. Review.

PMID:
21975737

Supplemental Content

Support Center